| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | cell morphogenesis | NES KIFBP ZFYVE27 HECW1 MAPT ACHE TPRN CDHR3 PPP1R9A MCF2 RILPL1 PIP5K1C CREB1 ADD1 PLEKHG4B COL18A1 ARHGEF40 SNAP91 FOXP1 NYAP1 BRWD1 | 5.71e-06 | 1194 | 121 | 21 | GO:0000902 |
| GeneOntologyBiologicalProcess | neuron development | KIFBP ZFYVE27 HECW1 MAP4 MAPT TNC ACHE TPRN PPP1R9A MCF2 PIP5K1C CREB1 PLEKHG4B ARHGEF40 SNAP91 RP1L1 BLOC1S3 FOXP1 PPP1R9B NYAP1 CNGB1 TNXB | 3.83e-05 | 1463 | 121 | 22 | GO:0048666 |
| GeneOntologyBiologicalProcess | neuron projection development | KIFBP ZFYVE27 HECW1 MAP4 MAPT TNC ACHE TPRN PPP1R9A MCF2 PIP5K1C CREB1 PLEKHG4B ARHGEF40 SNAP91 BLOC1S3 FOXP1 PPP1R9B NYAP1 TNXB | 5.64e-05 | 1285 | 121 | 20 | GO:0031175 |
| GeneOntologyCellularComponent | presynaptic endocytic zone membrane | 6.57e-05 | 14 | 121 | 3 | GO:0098835 | |
| GeneOntologyCellularComponent | basement membrane | 7.77e-05 | 122 | 121 | 6 | GO:0005604 | |
| GeneOntologyCellularComponent | presynaptic endocytic zone | 1.45e-04 | 18 | 121 | 3 | GO:0098833 | |
| GeneOntologyCellularComponent | axon | ZFYVE27 ANK1 MAP4 MAPT ACHE CDHR3 PPP1R9A CREB1 KCNQ5 SNAP91 BASP1 BLOC1S3 PPP1R9B USH2A CNGB1 | 1.98e-04 | 891 | 121 | 15 | GO:0030424 |
| GeneOntologyCellularComponent | tenascin complex | 1.98e-04 | 4 | 121 | 2 | GO:0090733 | |
| GeneOntologyCellularComponent | distal axon | ZFYVE27 MAPT CDHR3 PPP1R9A KCNQ5 SNAP91 BASP1 PPP1R9B USH2A CNGB1 | 2.22e-04 | 435 | 121 | 10 | GO:0150034 |
| GeneOntologyCellularComponent | extrinsic component of membrane | 3.89e-04 | 230 | 121 | 7 | GO:0019898 | |
| GeneOntologyCellularComponent | cilium | MAP4 MAPT SPEF2 FAM161B RILPL1 ALPK1 FSCB RP1L1 CLTB CFAP74 USH2A CNGB1 PCNT BRWD1 | 6.99e-04 | 898 | 121 | 14 | GO:0005929 |
| GeneOntologyCellularComponent | cell projection membrane | 9.15e-04 | 431 | 121 | 9 | GO:0031253 | |
| GeneOntologyCellularComponent | T-tubule | 1.15e-03 | 79 | 121 | 4 | GO:0030315 | |
| GeneOntologyCellularComponent | dendritic spine neck | 1.16e-03 | 9 | 121 | 2 | GO:0044326 | |
| GeneOntologyCellularComponent | postsynaptic density | 1.26e-03 | 451 | 121 | 9 | GO:0014069 | |
| GeneOntologyCellularComponent | neuron projection membrane | 1.32e-03 | 82 | 121 | 4 | GO:0032589 | |
| GeneOntologyCellularComponent | leading edge membrane | 1.41e-03 | 210 | 121 | 6 | GO:0031256 | |
| GeneOntologyCellularComponent | asymmetric synapse | 1.84e-03 | 477 | 121 | 9 | GO:0032279 | |
| GeneOntologyCellularComponent | Z disc | 1.87e-03 | 151 | 121 | 5 | GO:0030018 | |
| Domain | GAGE | GAGE4 GAGE5 GAGE6 GAGE12J GAGE12H GAGE12F GAGE12I GAGE2E GAGE13 GAGE1 | 2.67e-16 | 24 | 127 | 10 | PF05831 |
| Domain | GAGE_fam | GAGE4 GAGE5 GAGE6 GAGE12J GAGE12H GAGE12F GAGE12I GAGE2E GAGE13 GAGE1 | 4.42e-16 | 25 | 127 | 10 | IPR008625 |
| Domain | GAGE | 1.45e-07 | 19 | 127 | 5 | IPR031320 | |
| Domain | GAGE | 1.45e-07 | 19 | 127 | 5 | SM01379 | |
| Domain | MAGEA3/MAGEA6 | 4.59e-05 | 2 | 127 | 2 | IPR030097 | |
| Domain | SAP30_Sin3-bd | 4.59e-05 | 2 | 127 | 2 | IPR025718 | |
| Domain | SAP30_zn-finger | 4.59e-05 | 2 | 127 | 2 | IPR025717 | |
| Domain | SAP30_Sin3_bdg | 4.59e-05 | 2 | 127 | 2 | PF13867 | |
| Domain | zf-SAP30 | 4.59e-05 | 2 | 127 | 2 | PF13866 | |
| Domain | His_deAcase_SAP30/SAP30L | 4.59e-05 | 2 | 127 | 2 | IPR024145 | |
| Domain | TAU_MAP_1 | 1.37e-04 | 3 | 127 | 2 | PS00229 | |
| Domain | TAU_MAP_2 | 1.37e-04 | 3 | 127 | 2 | PS51491 | |
| Domain | Tubulin-binding | 1.37e-04 | 3 | 127 | 2 | PF00418 | |
| Domain | MAP_tubulin-bd_rpt | 1.37e-04 | 3 | 127 | 2 | IPR001084 | |
| Domain | MAP2/MAP4/Tau | 1.37e-04 | 3 | 127 | 2 | IPR027324 | |
| Domain | TACC | 1.37e-04 | 3 | 127 | 2 | PF05010 | |
| Domain | TACC | 1.37e-04 | 3 | 127 | 2 | IPR007707 | |
| Domain | PDZ | 4.07e-04 | 141 | 127 | 6 | PF00595 | |
| Domain | PDZ | 5.26e-04 | 148 | 127 | 6 | SM00228 | |
| Domain | JmjC | 5.60e-04 | 24 | 127 | 3 | PF02373 | |
| Domain | - | 5.65e-04 | 150 | 127 | 6 | 2.30.42.10 | |
| Domain | PDZ | 5.85e-04 | 151 | 127 | 6 | PS50106 | |
| Domain | PDZ | 6.06e-04 | 152 | 127 | 6 | IPR001478 | |
| Domain | Calx_beta | 1.25e-03 | 8 | 127 | 2 | SM00237 | |
| Domain | JMJC | 1.32e-03 | 32 | 127 | 3 | PS51184 | |
| Domain | JmjC_dom | 1.32e-03 | 32 | 127 | 3 | IPR003347 | |
| Domain | JmjC | 1.44e-03 | 33 | 127 | 3 | SM00558 | |
| Domain | Calx_beta | 1.60e-03 | 9 | 127 | 2 | IPR003644 | |
| Domain | Calx-beta | 1.60e-03 | 9 | 127 | 2 | PF03160 | |
| Domain | JmjN | 1.99e-03 | 10 | 127 | 2 | SM00545 | |
| Domain | JMJN | 1.99e-03 | 10 | 127 | 2 | PS51183 | |
| Domain | Ank_3 | 1.99e-03 | 10 | 127 | 2 | PF13606 | |
| Domain | JmjN | 1.99e-03 | 10 | 127 | 2 | PF02375 | |
| Domain | JmjN | 1.99e-03 | 10 | 127 | 2 | IPR003349 | |
| Pubmed | An overview of the GAGE cancer/testis antigen family with the inclusion of newly identified members. | GAGE4 GAGE5 GAGE6 GAGE7 GAGE12J GAGE12H GAGE12F GAGE12I GAGE2E GAGE13 GAGE1 | 4.16e-22 | 20 | 138 | 11 | 18179644 |
| Pubmed | 1.58e-15 | 10 | 138 | 7 | 9651357 | ||
| Pubmed | Characterization of the GAGE genes that are expressed in various human cancers and in normal testis. | 4.32e-15 | 11 | 138 | 7 | 10397259 | |
| Pubmed | A Genome-Wide CRISPR Screen Identifies Genes Critical for Resistance to FLT3 Inhibitor AC220. | GAGE5 GAGE6 GAGE7 GAGE12J GAGE12F GAGE12I GAGE2E GAGE13 GAGE12G GAGE1 | 5.12e-11 | 119 | 138 | 10 | 28625976 |
| Pubmed | 1.14e-10 | 9 | 138 | 5 | 7544395 | ||
| Pubmed | NES PPP1R9A GPKOW CREB1 TRIM28 AHNAK CLTB TP53BP1 AHNAK2 PCNT VAT1 | 2.24e-07 | 360 | 138 | 11 | 33111431 | |
| Pubmed | 2.44e-07 | 4 | 138 | 3 | 25679763 | ||
| Pubmed | 2.44e-07 | 4 | 138 | 3 | 17185750 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | MAP7D3 MAP4 PARG CHD1 TACC2 GLOD4 GPKOW ADD1 PTPN12 TRIM28 AHNAK PPP1R9B ACBD3 TP53BP1 AHNAK2 PCNT | 1.02e-06 | 934 | 138 | 16 | 33916271 |
| Pubmed | VGF NES KIFBP HECW1 PDE1B PPP1R9A SIK3 ADD1 SNAP91 BASP1 TRIM28 DCHS1 PPP1R9B TACC3 TP53BP1 PCNT | 1.51e-06 | 963 | 138 | 16 | 28671696 | |
| Pubmed | An expanded Oct4 interaction network: implications for stem cell biology, development, and disease. | 1.77e-06 | 91 | 138 | 6 | 20362542 | |
| Pubmed | 2.11e-06 | 7 | 138 | 3 | 28262558 | ||
| Pubmed | 2.25e-06 | 53 | 138 | 5 | 36265442 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | MAP4 MAPT PARG SAP30L SAP30 ADD1 ZBTB7A TRIM28 EIF2B5 NFRKB EIF3B TACC3 KDM4B TP53BP1 | 2.69e-06 | 774 | 138 | 14 | 15302935 |
| Pubmed | TPRN UGGT1 PPP1R9A PPM1E KRI1 CDCA2 PTPN7 PTPN12 BASP1 TMEM160 AHNAK CLTB PPP1R9B TPD52 PCNT VAT1 | 4.49e-06 | 1049 | 138 | 16 | 27880917 | |
| Pubmed | 6.73e-06 | 246 | 138 | 8 | 15345747 | ||
| Pubmed | 7.19e-06 | 10 | 138 | 3 | 27023172 | ||
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 8.99e-06 | 256 | 138 | 8 | 33397691 | |
| Pubmed | 1.31e-05 | 12 | 138 | 3 | 20181597 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 33961796 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 16143467 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 9321695 | ||
| Pubmed | Distinct roles for spinophilin and neurabin in dopamine-mediated plasticity. | 1.56e-05 | 2 | 138 | 2 | 16600521 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 30056111 | ||
| Pubmed | SOX10 induced Nestin expression regulates cancer stem cell properties of TNBC cells. | 1.56e-05 | 2 | 138 | 2 | 28189679 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 22294156 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 11847113 | ||
| Pubmed | TRIM28 represses transcription of endogenous retroviruses in neural progenitor cells. | 1.56e-05 | 2 | 138 | 2 | 25543143 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 31895100 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 15007166 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 17202312 | ||
| Pubmed | Ryanodine receptor-ankyrin interaction regulates internal Ca2+ release in mouse T-lymphoma cells. | 1.56e-05 | 2 | 138 | 2 | 7629097 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 15455729 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 7509489 | ||
| Pubmed | The effects of tenascin C knockdown on trabecular meshwork outflow resistance. | 1.56e-05 | 2 | 138 | 2 | 23882691 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 24361252 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 30871606 | ||
| Pubmed | Altered expression of brain acetylcholinesterase in FTDP-17 human tau transgenic mice. | 1.56e-05 | 2 | 138 | 2 | 21530001 | |
| Pubmed | Histone demethylases KDM4B and KDM6B promotes osteogenic differentiation of human MSCs. | 1.56e-05 | 2 | 138 | 2 | 22770241 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 8856503 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 28700667 | ||
| Pubmed | KDM6B cooperates with Tau and regulates synaptic plasticity and cognition via inducing VGLUT1/2. | 1.56e-05 | 2 | 138 | 2 | 36028572 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 20833135 | ||
| Pubmed | Invasion of melanoma in double knockout mice lacking tenascin-X and tenascin-C. | 1.56e-05 | 2 | 138 | 2 | 12359049 | |
| Pubmed | The change in tenascin expression in mouse uterus during early pregnancy. | 1.56e-05 | 2 | 138 | 2 | 9013311 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 25564441 | ||
| Pubmed | Neurabin contributes to hippocampal long-term potentiation and contextual fear memory. | 1.56e-05 | 2 | 138 | 2 | 18183288 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 35710311 | ||
| Pubmed | TACC3 expression is tightly regulated during early differentiation. | 1.56e-05 | 2 | 138 | 2 | 12711550 | |
| Pubmed | Cep120 and TACCs control interkinetic nuclear migration and the neural progenitor pool. | 1.70e-05 | 13 | 138 | 3 | 17920017 | |
| Pubmed | 3.30e-05 | 16 | 138 | 3 | 15878328 | ||
| Pubmed | TAG-1 Multifunctionality Coordinates Neuronal Migration, Axon Guidance, and Fasciculation. | 3.30e-05 | 16 | 138 | 3 | 31995756 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | MDFI KDM6B DYSF PIP5K1C SAP30 RYR1 ARHGEF40 TULP4 TRIM28 AHNAK SLC52A2 ZNF839 DOCK6 AHNAK2 PCNT | 3.52e-05 | 1105 | 138 | 15 | 35748872 |
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 4.04e-05 | 231 | 138 | 7 | 16452087 | |
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 20574536 | ||
| Pubmed | The TACC domain identifies a family of centrosomal proteins that can interact with microtubules. | 4.68e-05 | 3 | 138 | 2 | 11121038 | |
| Pubmed | Tenascin-C, tenascin-R and tenascin-X: a family of talented proteins in search of functions. | 4.68e-05 | 3 | 138 | 2 | 7694605 | |
| Pubmed | MAGE proteins regulate KRAB zinc finger transcription factors and KAP1 E3 ligase activity. | 4.68e-05 | 3 | 138 | 2 | 25107531 | |
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 15226440 | ||
| Pubmed | KAP1 Deacetylation by SIRT1 Promotes Non-Homologous End-Joining Repair. | 4.68e-05 | 3 | 138 | 2 | 25905708 | |
| Pubmed | Spinophilin/neurabin reciprocally regulate signaling intensity by G protein-coupled receptors. | 4.68e-05 | 3 | 138 | 2 | 17464283 | |
| Pubmed | The dynamic expression of tenascin-C and tenascin-X during early heart development in the mouse. | 4.68e-05 | 3 | 138 | 2 | 12823230 | |
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 24833716 | ||
| Pubmed | Neurabin is a synaptic protein linking p70 S6 kinase and the neuronal cytoskeleton. | 4.68e-05 | 3 | 138 | 2 | 9653190 | |
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 17611647 | ||
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 21940993 | ||
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 18384970 | ||
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 12847086 | ||
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 33191393 | ||
| Pubmed | Expression of tenascin in developing and adult mouse lymphoid organs. | 4.68e-05 | 3 | 138 | 2 | 7687262 | |
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 7530141 | ||
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 27266524 | ||
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 34058037 | ||
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 21276080 | ||
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 18638481 | ||
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 21277283 | ||
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 37258650 | ||
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 36476351 | ||
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 19696013 | ||
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 21172805 | ||
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 37209968 | ||
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 29633065 | ||
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 23091070 | ||
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 27298345 | ||
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 27922110 | ||
| Pubmed | The KDM4/JMJD2 histone demethylases are required for hematopoietic stem cell maintenance. | 4.68e-05 | 3 | 138 | 2 | 31434704 | |
| Pubmed | TRIM28 regulates the nuclear accumulation and toxicity of both alpha-synuclein and tau. | 4.68e-05 | 3 | 138 | 2 | 27779468 | |
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 19015240 | ||
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 25636512 | ||
| Pubmed | Spinophilin directs protein phosphatase 1 specificity by blocking substrate binding sites. | 4.68e-05 | 3 | 138 | 2 | 20305656 | |
| Pubmed | Expression of Fraser syndrome genes in normal and polycystic murine kidneys. | 4.68e-05 | 3 | 138 | 2 | 21993971 | |
| Pubmed | 4.98e-05 | 163 | 138 | 6 | 16512683 | ||
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 5.84e-05 | 430 | 138 | 9 | 35044719 | |
| Pubmed | 6.63e-05 | 20 | 138 | 3 | 35177643 | ||
| Pubmed | HBS1L MAP7D3 MAP4 ADD1 TRIM28 AHNAK NFRKB TACC3 TP53BP1 TPD52 | 7.20e-05 | 549 | 138 | 10 | 38280479 | |
| Pubmed | Broad histone H3K4me3 domains in mouse oocytes modulate maternal-to-zygotic transition. | 7.71e-05 | 21 | 138 | 3 | 27626377 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | MAP4 MAPT PPP1R9A RILPL1 SSX2 PLEKHG4B COL18A1 ZBTB7A KCNQ5 TULP4 FOXP1 PPP1R9B ZFHX3 ZNF839 DOCK6 KDM4B PCNT | 8.94e-05 | 1489 | 138 | 17 | 28611215 |
| Pubmed | 9.33e-05 | 4 | 138 | 2 | 15588513 | ||
| Pubmed | 9.33e-05 | 4 | 138 | 2 | 20152126 | ||
| Pubmed | 9.33e-05 | 4 | 138 | 2 | 21876767 | ||
| Interaction | FLT3 interactions | GAGE5 GAGE6 GAGE7 GAGE12J KRI1 GAGE12F GAGE12I GAGE2E PTPN12 GAGE13 GAGE12G GAGE1 | 8.97e-07 | 318 | 128 | 12 | int:FLT3 |
| Interaction | PRKACA interactions | MAPT FOS SIK3 CREB1 FSCB RYR1 ADD1 PTPN7 PTPN12 BASP1 PPP1R9B MAST3 TPD52 PCNT | 5.62e-06 | 519 | 128 | 14 | int:PRKACA |
| Cytoband | Xp11.23 | GAGE12J GPKOW GAGE12H GAGE12F GAGE12I GAGE2E GAGE13 GAGE12G GAGE1 | 1.55e-11 | 95 | 139 | 9 | Xp11.23 |
| Cytoband | Xp11.4-p11.2 | 1.20e-09 | 6 | 139 | 4 | Xp11.4-p11.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chrXp11 | GAGE12J SSX2 GPKOW GAGE12H GAGE12F GAGE2E GAGE13 GAGE12G GAGE1 | 2.48e-06 | 377 | 139 | 9 | chrXp11 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q11 | 2.03e-05 | 271 | 139 | 7 | chr7q11 | |
| Cytoband | 7q11.23 | 2.24e-04 | 97 | 139 | 4 | 7q11.23 | |
| GeneFamily | PDZ domain containing | 2.92e-05 | 152 | 71 | 6 | 1220 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 7.74e-05 | 181 | 71 | 6 | 694 | |
| GeneFamily | PHD finger proteins|Lysine demethylases | 1.11e-04 | 24 | 71 | 3 | 485 | |
| GeneFamily | Tudor domain containing | 4.10e-04 | 37 | 71 | 3 | 780 | |
| GeneFamily | Speedy/RINGO cell cycle regulator family | 9.78e-04 | 12 | 71 | 2 | 756 | |
| GeneFamily | Cadherin related | 1.99e-03 | 17 | 71 | 2 | 24 | |
| GeneFamily | Protein tyrosine phosphatases, non-receptor type | 2.23e-03 | 18 | 71 | 2 | 812 | |
| GeneFamily | Fibrinogen C domain containing | 4.30e-03 | 25 | 71 | 2 | 554 | |
| Coexpression | GSE41867_NAIVE_VS_DAY8_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_DN | 6.67e-06 | 199 | 129 | 8 | M9498 | |
| Coexpression | DALESSIO_TSA_RESPONSE | 7.70e-06 | 26 | 129 | 4 | M2340 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal-Mesoderm|6m / Sample Type, Dataset, Time_group, and Cell type. | 1.44e-07 | 200 | 131 | 8 | 0f6851baf0cf2a8b0c95a7a585c4407c330c5f6c | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-Pericytes-Immature_pericyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.95e-07 | 178 | 131 | 7 | e5e4742e35c3d90f82b830d77bdbdc45828c7deb | |
| ToppCell | droplet-Bladder-BLADDER-1m-Endothelial-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.95e-07 | 178 | 131 | 7 | 6bef4ef48f649c6e38ae732bc08e6d7814db588b | |
| ToppCell | control-Myeloid-Neutrophils_1|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.59e-06 | 191 | 131 | 7 | db1b3cd07d7d190155b2d14e82e1d124975fbd0b | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-06 | 194 | 131 | 7 | ba529c051f248d29f4222f4bc9801ba233859093 | |
| ToppCell | mild-Myeloid-Neutrophils_1|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.77e-06 | 194 | 131 | 7 | ccd911ce3251cd1c60f1fb2ce00650fbe7a379bb | |
| ToppCell | control-Myeloid-Neutrophils_1|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.89e-06 | 196 | 131 | 7 | 9c8623232c47af5de9f360fd5c5113362e37c6c9 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Intermediate|5w / Sample Type, Dataset, Time_group, and Cell type. | 2.16e-06 | 200 | 131 | 7 | c92e4fc0442404481fcac623d691dae6215b852d | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sfrp2-Inhibitory_Neuron.Gad1Gad2_Id2.Sfrp2_(Interneuron,_Neurogliaform1)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.48e-06 | 73 | 131 | 5 | cc89c94a3768b02036757dea86989d9284b214b9 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sfrp2|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.48e-06 | 73 | 131 | 5 | 6f28d52700bab981c8a3664ba4762f3572f7e788 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sfrp2-Inhibitory_Neuron.Gad1Gad2_Id2.Sfrp2_(Interneuron,_Neurogliaform1)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.48e-06 | 73 | 131 | 5 | ae80fcf3544c18fe0318a8311e96f2448f7cb03c | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.02e-05 | 167 | 131 | 6 | 784776d1fcc098f84d3c2eca58fa56cb9428f434 | |
| ToppCell | healthy_donor-Myeloid-Monocytic-Neutrophil|healthy_donor / Disease condition, Lineage, Cell class and subclass | 1.05e-05 | 168 | 131 | 6 | 04259f5a9b067cd1b5619e34591e4b2fccc18535 | |
| ToppCell | NS-moderate-d_07-13-Lymphoid-NK|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.33e-05 | 175 | 131 | 6 | f6cd24d22f62469319f9d244e3e5de527d3d4d94 | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-myeloid_dendritic_cell-proliferating_dendritic|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.33e-05 | 175 | 131 | 6 | 73f25bd54309aed1480ddc44bdab518b17e71f92 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.71e-05 | 183 | 131 | 6 | c5b10571599dc26476170b54b53f09c23e6b3117 | |
| ToppCell | Endothelial-A-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 1.71e-05 | 183 | 131 | 6 | 2c3f2c25c38f0598b4787d2ec335efe00fdc9751 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.76e-05 | 184 | 131 | 6 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.88e-05 | 186 | 131 | 6 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-18m-Lymphocytic|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.93e-05 | 187 | 131 | 6 | e53471c3e146a6f54788d81ecc469aba55b051bb | |
| ToppCell | facs-Diaphragm-Limb_Muscle-18m-Lymphocytic-nan|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.93e-05 | 187 | 131 | 6 | 3d7d51fbadb20dc884d0b3c0d61b80f022b19d09 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.99e-05 | 188 | 131 | 6 | 0d86044bc340e3efb90d0022dd299873639d831c | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.99e-05 | 188 | 131 | 6 | beb2df2332a46cc81b10e8e29fc9829020111f03 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.99e-05 | 188 | 131 | 6 | 3cfba3addcc9058f4ec31ad96261f79988f551a0 | |
| ToppCell | P07-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.99e-05 | 188 | 131 | 6 | 6ec22b79b19d57ea187f312907819dc2d01f3efe | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.05e-05 | 189 | 131 | 6 | 7659c7bbd58ee959a159294fb8d17317bbcc5681 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_intermediate_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.11e-05 | 190 | 131 | 6 | c95032bb3ee2b3d40fdf48016acb46d6f78a48a6 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.11e-05 | 190 | 131 | 6 | 625c08a0e5227efc46daa512fd579c3938ff76c7 | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.11e-05 | 190 | 131 | 6 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | COVID-19-Heart-Mito_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.11e-05 | 190 | 131 | 6 | ea74e0e38bcaba125b48c88331e9ba09228d3178 | |
| ToppCell | wk_20-22-Endothelial-Lymph_endothelial|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.18e-05 | 191 | 131 | 6 | 631f95fd80dd3678b5b2ef201abf7fe646049af6 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.18e-05 | 191 | 131 | 6 | 63aa671837b79d2feb7ed1e67712cc01caf72bef | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs_st-18m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-05 | 192 | 131 | 6 | 6806a1a9fe00395dc1abc3e0124b4261dc701f31 | |
| ToppCell | 11.5-Airway-Epithelial-Bud_tip_adjacent|Airway / Age, Tissue, Lineage and Cell class | 2.24e-05 | 192 | 131 | 6 | fbb34a959b9bd9cb72a5195a07f4653a957e4ca8 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_airway-epi_intermediate_(1)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.24e-05 | 192 | 131 | 6 | b73f24d1c55dfef1eb01c26da117dbf637ea080a | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.31e-05 | 193 | 131 | 6 | d8ccfb780a75bdf9141f41fb29a076958601ebb4 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.31e-05 | 193 | 131 | 6 | b38aaffbea36ef6c08ebe82675438f873c89b242 | |
| ToppCell | LA-14._Fibroblast_III|LA / Chamber and Cluster_Paper | 2.31e-05 | 193 | 131 | 6 | 7426c291bac59e539c427bcaae18abc7d397d44e | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_alveolar-distal-epi_CTGF^high_distal_(3)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.38e-05 | 194 | 131 | 6 | c5ef4ff73b4e51530656002e3a2fb7264cdf533d | |
| ToppCell | control-Lymphocytic-CD4_T_cells_2|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.38e-05 | 194 | 131 | 6 | c2ae2ea848d78725455dcb6be9f1d8933745fa80 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_proliferating-epi_proliferating3_(5)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.38e-05 | 194 | 131 | 6 | c011cd59bb4ca4134331cba0f5d73bdbd7011d64 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_airway|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.38e-05 | 194 | 131 | 6 | 7b2b40a56eb9c7203ca50133b2da4fd8fdd4a5cf | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor2_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.38e-05 | 194 | 131 | 6 | 6b286992d4bb56013c0ea5a7601d3476d806175a | |
| ToppCell | PCW_07-8.5-Epithelial|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.38e-05 | 194 | 131 | 6 | f63ceedb88a9abc8644ee94adfd541e7817c1e3a | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.38e-05 | 194 | 131 | 6 | f95c8dc242c9aebcadfe61b1ed033349cb7e5a88 | |
| ToppCell | Smart-seq2-thymus_(Smart-seq2)-myeloid-myeloid_monocytic|thymus_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.45e-05 | 195 | 131 | 6 | ae98215b7b7f22f1aca690920ce6092dc4a3c7db | |
| ToppCell | Smart-seq2-thymus_(Smart-seq2)-myeloid-myeloid_monocytic-monocyte|thymus_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.45e-05 | 195 | 131 | 6 | 6fcab7aa4db958ccad0300adea9aaae52ace5bff | |
| ToppCell | PBMC-Control-cDC_3|Control / Compartment, Disease Groups and Clusters | 2.52e-05 | 196 | 131 | 6 | 09d197b321ff9f13c0672ea059c850845b0dbbd5 | |
| ToppCell | mLN-T_cell-Th1|T_cell / Region, Cell class and subclass | 2.59e-05 | 197 | 131 | 6 | 5e39a49dddef04469ff2b615d755ddf6a926e58e | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.67e-05 | 198 | 131 | 6 | f261a37dd07976548b897af86df1d1a0dc069889 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_A-Branch_A2_(IPAN/IN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.67e-05 | 198 | 131 | 6 | 7b9c7ce5d6b7df8db85943b65da1a2c202a8bb53 | |
| ToppCell | mLN-T_cell-Th1|mLN / Region, Cell class and subclass | 2.67e-05 | 198 | 131 | 6 | 7627b7c3a248da2bd5e1e6f7c226e5fd0bc92113 | |
| ToppCell | mLN-(1)_T_cell-(12)_Th1|mLN / shred on region, Cell_type, and subtype | 2.67e-05 | 198 | 131 | 6 | 1fe8257233232b264b9ca630c2d92c509a195353 | |
| ToppCell | moderate-Myeloid-Neutrophil|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.67e-05 | 198 | 131 | 6 | a6306dac34af5783f3a734ef1eaa7a0c03267b4f | |
| ToppCell | wk_08-11-Epithelial-Airway_epithelial_progenitor-epi-stalk_intermediate|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.74e-05 | 199 | 131 | 6 | debdd7dba774d9ccff7effc3f4c132393d203dfa | |
| ToppCell | mild-Neutrophil|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.74e-05 | 199 | 131 | 6 | ca319976a7d2576186d0a98cdc93e4c2d5fe8a05 | |
| ToppCell | wk_08-11-Epithelial-Airway_epithelial_progenitor|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.74e-05 | 199 | 131 | 6 | af664e0d41a889a75dbf6cf0d50acd26f5ab3a3a | |
| ToppCell | COVID-19-COVID-19_Mild-Myeloid-Neutrophil|COVID-19_Mild / Disease, condition lineage and cell class | 2.74e-05 | 199 | 131 | 6 | 9f6b6731186ef399f952a75879eba66fd8ed3494 | |
| ToppCell | Control-Control-Myeloid-Neutrophil|Control / Disease, condition lineage and cell class | 2.82e-05 | 200 | 131 | 6 | 95c41f147a1594d49e73cb56d86d301c3115ce20 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.82e-05 | 200 | 131 | 6 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Cortical_neuron|5w / Sample Type, Dataset, Time_group, and Cell type. | 2.82e-05 | 200 | 131 | 6 | 085060d148158f7d9e938b6c4a3700ccbb3bca15 | |
| ToppCell | COVID-19-COVID-19_Severe-Myeloid-Neutrophil|COVID-19_Severe / Disease, condition lineage and cell class | 2.82e-05 | 200 | 131 | 6 | fec2660c9a9977b3b3a2eaed063b9049c0b07ff2 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal|5w / Sample Type, Dataset, Time_group, and Cell type. | 2.82e-05 | 200 | 131 | 6 | 9b5753726c17dda98d7384a60f26a5eaf4f6c4d6 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-Macroglial|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 2.82e-05 | 200 | 131 | 6 | be1abe5bb1ce4e7dfec63af4ed0fc5b96bf77866 | |
| ToppCell | COVID-19-Heart-CM_5_(RYR2-)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.74e-05 | 144 | 131 | 5 | f92e03dd784e31a9e5dbd4f4c3a6517ea19210cf | |
| ToppCell | Severe-B_naive-8|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 6.97e-05 | 145 | 131 | 5 | a24cad86509208bc7267b02ef1d1b0a25a2a7043 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.71e-05 | 152 | 131 | 5 | b61d2f6ee819c8dd4b4b601a8bc8388b1983de58 | |
| ToppCell | droplet-Fat-SCAT-30m-Myeloid-monocyte|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.98e-05 | 153 | 131 | 5 | 2731c3d4ac40ecc22108f8f3f45a069077159125 | |
| ToppCell | LPS-IL1RA+antiTNF-Unknown-Endothelial-Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.26e-05 | 154 | 131 | 5 | 16fdafb5c64d2db321554f87129a962d113f1668 | |
| ToppCell | COVID-19-Heart-CM_5_(RYR2-)|Heart / Disease (COVID-19 only), tissue and cell type | 9.55e-05 | 155 | 131 | 5 | d7e26696fd9c0a759524f331243db43059b33ed9 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD4-Tregs|GI_small-bowel / Manually curated celltypes from each tissue | 9.55e-05 | 155 | 131 | 5 | d4ef25965a15eab7679478b9b661e1b4a92f1c59 | |
| ToppCell | E16.5-samps-Mesenchymal-Myofibroblast-Migrating_MyoFibroblast|E16.5-samps / Age Group, Lineage, Cell class and subclass | 9.55e-05 | 155 | 131 | 5 | 1882fa5fd25f77d6e3ac47b613f6fb3c67d8e50c | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.55e-05 | 155 | 131 | 5 | 77fdae85d36efb776db977eb424b32487ef222e4 | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Myofibro_2|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.01e-04 | 157 | 131 | 5 | b9d04ee417c0d8ea0801d10f1c54e138587009fd | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L6_LHX6_GLP1R|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.08e-04 | 159 | 131 | 5 | 5a322abc2f16cb3fcec2a232093520315567a5ff | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.17e-04 | 162 | 131 | 5 | 5c9bc3c3857a99d8a3caf359a7eb279ce9cc1c81 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_ciliated-epi_ciliated_(14)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.28e-04 | 165 | 131 | 5 | 0c714e852f912b5749de4cb0895406673979b2e6 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_ciliated|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.28e-04 | 165 | 131 | 5 | 82530f96aaefe28a13bad0474bbad043f127a86c | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.35e-04 | 167 | 131 | 5 | b4ef07117d14da3d5fbced949e4dfcb01c392295 | |
| ToppCell | TCGA-Mesothelium-Primary_Tumor-Mesothelioma-Biphasic|TCGA-Mesothelium / Sample_Type by Project: Shred V9 | 1.35e-04 | 167 | 131 | 5 | 9062577a4b7902c9a888d706589d1b05221c0fa8 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.35e-04 | 167 | 131 | 5 | 94fc7df7ca55cd722a8dbd153201a29891217473 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.35e-04 | 167 | 131 | 5 | eff3723fe60755272eca237459165e436e919ece | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-kidney_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-04 | 168 | 131 | 5 | f45dbcd7753117a3e41e1412bce2100d52fa7fd0 | |
| ToppCell | facs-Large_Intestine-Distal-3m-Epithelial-enterocyte_of_epithelium_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-04 | 168 | 131 | 5 | 03896466698a79f7f1ad862cb7e05585260e2a5a | |
| ToppCell | CTRL-Myeloid-Neutrophil|Myeloid / Disease state, Lineage and Cell class | 1.47e-04 | 170 | 131 | 5 | 151dabe1d240dde414c881bf4fa816c69fa1c32d | |
| ToppCell | 390C-Lymphocytic-ILC|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.51e-04 | 171 | 131 | 5 | 70963f79711fe6088d6d01b29206b17ab89e5e73 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.51e-04 | 171 | 131 | 5 | 4ede831aed364cb5271f49a8b09bb6d0452f9b35 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-monocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-04 | 171 | 131 | 5 | 992df143d76f9e7fb1997a8996f61e941f0f9d4f | |
| ToppCell | CTRL-Myeloid-Neutrophil|CTRL / Disease state, Lineage and Cell class | 1.55e-04 | 172 | 131 | 5 | ef3a6fe3b7300959f9f71130200c7fb8741c42b0 | |
| ToppCell | 390C-Lymphocytic-ILC-ILC-2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.55e-04 | 172 | 131 | 5 | 84d16cd7f618c94888920680bdc9e7130d73fd75 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Classical_Dendritic_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.60e-04 | 173 | 131 | 5 | 73f858f2c45d19b9ec8d99ac02c91551790f670c | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.64e-04 | 174 | 131 | 5 | e2243f1e48e3275753a2b3a69d06eefce69a8ded | |
| ToppCell | CF-Myeloid-Neutrophil|Myeloid / Disease state, Lineage and Cell class | 1.68e-04 | 175 | 131 | 5 | 8020c3a34f77e68e8149f87481fb1dddd2ac675e | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l2|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.73e-04 | 176 | 131 | 5 | 8f9d2a763b79cafe26dcbf3dba980d473a0b9873 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.73e-04 | 176 | 131 | 5 | 6c7edf1cb38644500bce6c5a1dd90bbe17415cdb | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-classical_monocyte|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.73e-04 | 176 | 131 | 5 | 3b5d12d5c22e32fbe80c3716ff14a7ae5769c165 | |
| ToppCell | 390C-Endothelial_cells-Endothelial-E-|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.82e-04 | 178 | 131 | 5 | 804ac3725c1f88e2212172bfb9aa01d97a735621 | |
| ToppCell | 390C-Endothelial_cells-Endothelial-E|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.82e-04 | 178 | 131 | 5 | ad6dc4a375664c919bd48c35c48a561fc5a7de8c | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.87e-04 | 179 | 131 | 5 | 815b959ce8721c5ded70c0ca6e318dafc691746e | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.92e-04 | 180 | 131 | 5 | f2f6e83127a4a415e65c76a35efa8175fbd5b5d9 | |
| Drug | retinoic acid; Down 200; 1uM; MCF7; HT_HG-U133A | 1.98e-06 | 195 | 131 | 9 | 6971_DN | |
| Drug | BIX 02189 | 3.68e-06 | 6 | 131 | 3 | ctd:C533207 | |
| Disease | cholesterol in large HDL measurement | 1.93e-05 | 80 | 120 | 5 | EFO_0021900 | |
| Disease | neutrophil count | NES HBS1L MAPT KRI1 SIK3 TEX14 KDM6B RP1L1 FOXP1 DOCK6 MAP2K5 ACBD3 TNXB KDM4B PCNT VAT1 | 1.54e-04 | 1382 | 120 | 16 | EFO_0004833 |
| Disease | medulloblastoma (is_marker_for) | 1.63e-04 | 5 | 120 | 2 | DOID:0050902 (is_marker_for) | |
| Disease | Developmental Academic Disorder | 2.22e-04 | 29 | 120 | 3 | C1330966 | |
| Disease | Learning Disorders | 2.22e-04 | 29 | 120 | 3 | C0023186 | |
| Disease | Learning Disturbance | 2.22e-04 | 29 | 120 | 3 | C0751263 | |
| Disease | Adult Learning Disorders | 2.22e-04 | 29 | 120 | 3 | C0751262 | |
| Disease | Learning Disabilities | 2.22e-04 | 29 | 120 | 3 | C0751265 | |
| Disease | primary ciliary dyskinesia (is_implicated_in) | 2.43e-04 | 6 | 120 | 2 | DOID:9562 (is_implicated_in) | |
| Disease | age at diagnosis, osteoarthritis | 3.40e-04 | 7 | 120 | 2 | EFO_0004918, MONDO_0005178 | |
| Disease | Pick's disease (is_marker_for) | 3.40e-04 | 7 | 120 | 2 | DOID:11870 (is_marker_for) | |
| Disease | eosinophil count | HBS1L KIFBP KDM4C MAPT SPEF2 CHD1 SIK3 KDM6B DYSF ZBTB7A CD300LG FOXP1 TNXB TP53BP1 MAST3 TPD52 | 3.53e-04 | 1488 | 120 | 16 | EFO_0004842 |
| Disease | basophil percentage of leukocytes | 4.90e-04 | 243 | 120 | 6 | EFO_0007992 | |
| Disease | heart rate response to exercise | 7.19e-04 | 43 | 120 | 3 | EFO_0009184 | |
| Disease | Memory Loss | 7.19e-04 | 43 | 120 | 3 | C0751295 | |
| Disease | Age-Related Memory Disorders | 7.19e-04 | 43 | 120 | 3 | C0751292 | |
| Disease | Memory Disorder, Spatial | 7.19e-04 | 43 | 120 | 3 | C0751294 | |
| Disease | Memory Disorder, Semantic | 7.19e-04 | 43 | 120 | 3 | C0751293 | |
| Disease | Memory Disorders | 7.19e-04 | 43 | 120 | 3 | C0025261 | |
| Disease | tenascin measurement | 7.23e-04 | 10 | 120 | 2 | EFO_0008296 | |
| Disease | tauopathy (implicated_via_orthology) | 7.23e-04 | 10 | 120 | 2 | DOID:680 (implicated_via_orthology) | |
| Disease | alopecia areata (is_marker_for) | 7.23e-04 | 10 | 120 | 2 | DOID:986 (is_marker_for) | |
| Disease | Memory impairment | 7.69e-04 | 44 | 120 | 3 | C0233794 | |
| Disease | Retinitis Pigmentosa | 8.74e-04 | 104 | 120 | 4 | C0035334 | |
| Disease | triglyceride measurement, high density lipoprotein cholesterol measurement | 9.16e-04 | 274 | 120 | 6 | EFO_0004530, EFO_0004612 | |
| Disease | heart failure | 9.77e-04 | 185 | 120 | 5 | EFO_0003144 | |
| Disease | metabolite measurement, body weight gain | 1.05e-03 | 12 | 120 | 2 | EFO_0004566, EFO_0004725 | |
| Disease | triglycerides to total lipids in medium LDL percentage | 1.12e-03 | 50 | 120 | 3 | EFO_0022334 | |
| Disease | cholesteryl esters to total lipids in IDL percentage | 1.12e-03 | 50 | 120 | 3 | EFO_0022247 | |
| Disease | triglycerides to total lipids in large LDL percentage | 1.18e-03 | 51 | 120 | 3 | EFO_0022331 | |
| Disease | polyunsaturated fatty acids to monounsaturated fatty acids ratio | 1.18e-03 | 51 | 120 | 3 | EFO_0022302 | |
| Disease | Huntington's disease (is_marker_for) | 1.32e-03 | 53 | 120 | 3 | DOID:12858 (is_marker_for) | |
| Disease | cholesterol to total lipids in large HDL percentage | 1.48e-03 | 55 | 120 | 3 | EFO_0022234 | |
| Disease | phospholipids in medium HDL measurement | 1.48e-03 | 55 | 120 | 3 | EFO_0022295 | |
| Disease | triglycerides in very large VLDL measurement | 1.55e-03 | 56 | 120 | 3 | EFO_0022325 | |
| Disease | triglycerides to total lipids in medium HDL percentage | 1.55e-03 | 56 | 120 | 3 | EFO_0022333 | |
| Disease | cholesteryl esters to total lipids in medium HDL percentage | 1.55e-03 | 56 | 120 | 3 | EFO_0022251 | |
| Disease | mean reticulocyte volume | HBS1L FAM114A1 ANK1 KDM4C MAPT CHD1 SPDYE12 ZBTB7A FOXP1 TACC3 | 1.60e-03 | 799 | 120 | 10 | EFO_0010701 |
| Disease | free cholesterol to total lipids in medium VLDL percentage | 1.64e-03 | 57 | 120 | 3 | EFO_0022284 | |
| Disease | Body Weight | 1.66e-03 | 15 | 120 | 2 | C0005910 | |
| Disease | total lipids in medium HDL measurement | 1.72e-03 | 58 | 120 | 3 | EFO_0022310 | |
| Disease | free cholesterol in medium HDL measurement | 1.72e-03 | 58 | 120 | 3 | EFO_0022267 | |
| Disease | triglycerides in VLDL measurement | 1.81e-03 | 59 | 120 | 3 | EFO_0022326 | |
| Disease | triglycerides to total lipids in small LDL percentage | 1.81e-03 | 59 | 120 | 3 | EFO_0022337 | |
| Disease | cholesterol in medium HDL measurement | 1.81e-03 | 59 | 120 | 3 | EFO_0021903 | |
| Disease | cholesteryl esters to total lipids in large HDL percentage | 1.81e-03 | 59 | 120 | 3 | EFO_0022248 | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 1.88e-03 | 128 | 120 | 4 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 1.88e-03 | 128 | 120 | 4 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 1.88e-03 | 128 | 120 | 4 | C1266044 | |
| Disease | Papillary Renal Cell Carcinoma | 1.88e-03 | 128 | 120 | 4 | C1306837 | |
| Disease | Renal Cell Carcinoma | 1.88e-03 | 128 | 120 | 4 | C0007134 | |
| Disease | triglycerides to total lipids in large HDL percentage | 1.90e-03 | 60 | 120 | 3 | EFO_0022330 | |
| Disease | cholesterol in chylomicrons and extremely large VLDL measurement | 1.90e-03 | 60 | 120 | 3 | EFO_0021898 | |
| Disease | cholesterol to total lipids in IDL percentage | 1.90e-03 | 60 | 120 | 3 | EFO_0022233 | |
| Disease | cholesterol to total lipids in medium HDL percentage | 1.90e-03 | 60 | 120 | 3 | EFO_0022237 | |
| Disease | triglycerides in small VLDL measurement | 1.99e-03 | 61 | 120 | 3 | EFO_0022145 | |
| Disease | free cholesterol in very large VLDL measurement | 1.99e-03 | 61 | 120 | 3 | EFO_0022274 | |
| Disease | free cholesterol in HDL measurement | 1.99e-03 | 61 | 120 | 3 | EFO_0022264 | |
| Disease | phospholipids in HDL measurement | 1.99e-03 | 61 | 120 | 3 | EFO_0022293 | |
| Disease | testosterone measurement | MAPT ACHE TPRN KDM6B CREB1 CDCA2 ARHGEF40 KCNQ5 TMEM160 FOXP1 ZFHX3 USH2A BRWD1 | 2.08e-03 | 1275 | 120 | 13 | EFO_0004908 |
| Disease | triglycerides in small HDL measurement | 2.08e-03 | 62 | 120 | 3 | EFO_0022158 | |
| Disease | phospholipids in large VLDL measurement | 2.08e-03 | 62 | 120 | 3 | EFO_0022169 | |
| Disease | triglycerides to total lipids in very large HDL percentage | 2.08e-03 | 62 | 120 | 3 | EFO_0022339 | |
| Disease | total lipids in very large VLDL measurement | 2.08e-03 | 62 | 120 | 3 | EFO_0022313 | |
| Disease | phospholipids in very large VLDL measurement | 2.08e-03 | 62 | 120 | 3 | EFO_0022299 | |
| Disease | respiratory symptom change measurement, response to placebo | 2.14e-03 | 17 | 120 | 2 | EFO_0008344, EFO_0010068 | |
| Disease | very low density lipoprotein particle size measurement | 2.16e-03 | 133 | 120 | 4 | EFO_0008594 | |
| Disease | triglycerides to total lipids in IDL percentage | 2.18e-03 | 63 | 120 | 3 | EFO_0022329 | |
| Disease | triglycerides to total lipids in medium VLDL percentage | 2.18e-03 | 63 | 120 | 3 | EFO_0022335 | |
| Disease | total lipids in HDL measurement | 2.18e-03 | 63 | 120 | 3 | EFO_0022307 | |
| Disease | cholesterol to total lipids in medium VLDL percentage | 2.18e-03 | 63 | 120 | 3 | EFO_0022239 | |
| Disease | free cholesterol to total lipids in medium LDL percentage | 2.18e-03 | 63 | 120 | 3 | EFO_0022283 | |
| Disease | phospholipids in chylomicrons and extremely large VLDL measurement | 2.18e-03 | 63 | 120 | 3 | EFO_0022292 | |
| Disease | triglycerides in small LDL measurement | 2.38e-03 | 65 | 120 | 3 | EFO_0022323 | |
| Disease | cholesterol in large VLDL measurement | 2.38e-03 | 65 | 120 | 3 | EFO_0021902 | |
| Disease | esophageal adenocarcinoma | 2.40e-03 | 18 | 120 | 2 | EFO_0000478 | |
| Disease | phospholipids:total lipids ratio, intermediate density lipoprotein measurement | 2.60e-03 | 67 | 120 | 3 | EFO_0008595, EFO_0020946 | |
| Disease | cholesterol to total lipids in very small VLDL percentage | 2.60e-03 | 67 | 120 | 3 | EFO_0022245 | |
| Disease | triglycerides to phosphoglycerides ratio | 2.71e-03 | 68 | 120 | 3 | EFO_0022327 | |
| Disease | free cholesterol in large VLDL measurement | 2.71e-03 | 68 | 120 | 3 | EFO_0022265 | |
| Disease | triglycerides to total lipids in very small VLDL percentage | 2.83e-03 | 69 | 120 | 3 | EFO_0022341 | |
| Disease | Alzheimer disease, age at onset | 2.85e-03 | 343 | 120 | 6 | EFO_0004847, MONDO_0004975 | |
| Disease | colorectal adenoma (is_marker_for) | 2.97e-03 | 20 | 120 | 2 | DOID:0050860 (is_marker_for) | |
| Disease | Osteoarthritis of hip | 2.97e-03 | 20 | 120 | 2 | C0029410 | |
| Disease | alpha-tocopherol measurement | 2.97e-03 | 20 | 120 | 2 | EFO_0007898 | |
| Disease | cholesteryl esters to total lipids in very small VLDL percentage | 3.07e-03 | 71 | 120 | 3 | EFO_0022259 | |
| Disease | basophil count, eosinophil count | 3.10e-03 | 241 | 120 | 5 | EFO_0004842, EFO_0005090 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 3.18e-03 | 148 | 120 | 4 | C0279702 | |
| Disease | triglycerides to total lipids in small HDL percentage | 3.19e-03 | 72 | 120 | 3 | EFO_0022336 | |
| Disease | red blood cell density measurement | HBS1L ANK1 MAPT SIK3 KDM6B ZBTB7A ARHGEF40 BLOC1S3 FOXP1 SENP7 | 3.21e-03 | 880 | 120 | 10 | EFO_0007978 |
| Disease | level of Phosphatidylinositol (18:0_18:2) in blood serum | 3.27e-03 | 21 | 120 | 2 | OBA_2045156 | |
| Disease | osteoarthritis, hip, osteoarthritis, knee, total joint arthroplasty | 3.27e-03 | 21 | 120 | 2 | EFO_0004616, EFO_0010726, EFO_1000786 | |
| Disease | phospholipids in large HDL measurement | 3.32e-03 | 73 | 120 | 3 | EFO_0022190 | |
| Disease | migraine disorder, endometriosis | 3.32e-03 | 73 | 120 | 3 | EFO_0001065, MONDO_0005277 | |
| Disease | Retinitis pigmentosa | 3.45e-03 | 74 | 120 | 3 | cv:C0035334 | |
| Disease | total lipids in large HDL | 3.45e-03 | 74 | 120 | 3 | EFO_0022189 | |
| Disease | free cholesterol to total lipids in large LDL percentage | 3.45e-03 | 74 | 120 | 3 | EFO_0022280 | |
| Disease | eosinophil percentage of leukocytes | 3.48e-03 | 746 | 120 | 9 | EFO_0007991 | |
| Disease | Amphetamine-Related Disorders | 3.58e-03 | 75 | 120 | 3 | C0236733 | |
| Disease | Amphetamine Abuse | 3.58e-03 | 75 | 120 | 3 | C0236807 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VPVVDGDFLSDTPEA | 331 | P22303 | |
| GPESEVRTEPAAEAE | 61 | P55884 | |
| LEVSEPPAEAVGEAS | 331 | Q8TER5 | |
| HEEVTVEGPLEDPSE | 1846 | P16157 | |
| PLTEEEEEEGAGATL | 61 | Q96CA5 | |
| IDVSGPSVDTDAPDL | 1741 | Q09666 | |
| APSEGSAEAAPELDL | 481 | O60641 | |
| SGEPVPISEESEELD | 1396 | O14646 | |
| PGESSSEDEEPLAEL | 51 | Q5SZJ8 | |
| DPEGETAESTEDAPL | 786 | Q96QP1 | |
| AVPTEEEPDSAAKSG | 186 | Q9UF12 | |
| VAEVEESPETAAHPG | 271 | P35236 | |
| GPPIEDAIASSDVLE | 196 | Q9Y450 | |
| ALDGIPIEPSETDSA | 1056 | Q6ZRR7 | |
| ALSAESGLEPPDDTE | 3281 | Q96JQ0 | |
| QFSDEVEPATPEEGE | 31 | P0DTW1 | |
| VEVTLGEVPAAESPD | 46 | P43357 | |
| VEVTLGEVPAAESPD | 46 | P43360 | |
| LADALTEPSPDIEGE | 6 | P27816 | |
| EDLAEPLSSTEGVAP | 331 | Q6P4R8 | |
| QFSDEVEPATPEEGE | 31 | O76087 | |
| GLPEVATPESEEAFT | 226 | P01100 | |
| TEEFPIGEASAEVSP | 726 | Q5H9T9 | |
| PLTEVAEGVFETEAP | 121 | Q9HC38 | |
| SALEEDREEPEGATP | 611 | Q76N89 | |
| PAVPSREAEGEETEL | 191 | Q6UX15 | |
| SAAEEFEPISSDEGP | 1396 | Q2LD37 | |
| VGPEETETDTFDAAP | 876 | Q9NR82 | |
| EFPTVATVEIVDPGD | 1866 | Q5SZK8 | |
| ATVEIVDPGDEPTVF | 1871 | Q5SZK8 | |
| QFSDEVEPATPEEGE | 31 | Q4V326 | |
| ADPVDTAEPADSGTE | 936 | O15054 | |
| ESAAPAAGEEPSKEE | 131 | P80723 | |
| EGAAVSEEPSFIPEA | 516 | Q8N6G6 | |
| GSVISLHPPDAEEDE | 446 | Q13144 | |
| VDEDSPVLPVGEFSE | 376 | Q13163 | |
| DVVPESPLSDVGSED | 256 | Q86W56 | |
| SLDVEVGDPNPDVVS | 466 | Q01064 | |
| SAESPDAPEENIAGV | 96 | P39060 | |
| DPEEAEGPLSLVTTA | 641 | Q9H334 | |
| GSEEAEEDVPPVLVS | 1206 | P48681 | |
| EASPFSGEEDVSDPD | 636 | O94953 | |
| VSDEVDGAEVPNPDS | 391 | Q9H3R0 | |
| DGAEVPNPDSVTDDL | 396 | Q9H3R0 | |
| PPESFADTEAGEELS | 21 | Q96MY7 | |
| GEGADSEPRAETVPE | 141 | Q92917 | |
| PPVQLAVDDSSDEGE | 271 | Q8N9T8 | |
| EVSVDGLTLSPDPEE | 11 | Q9H3P7 | |
| SIVVEPSEADPVESG | 41 | A0A0U1RRK4 | |
| PATAADESPASEGEE | 171 | Q8N594 | |
| DGEEPDISPHIDTCD | 2116 | O95613 | |
| EVEGLASAPIEEVSP | 436 | Q9H6S3 | |
| PGEEAATVAATEEGD | 66 | Q8WY54 | |
| PDGDINISIPDTVEA | 681 | Q86SP6 | |
| PEAEGVVLSDSPDAA | 191 | Q8NI37 | |
| PDLAVAPGSVDDEVS | 886 | Q96HP0 | |
| QFSDEVEPATPEEGE | 31 | A1L429 | |
| QFSDEVEPATPEEGE | 31 | P0CL80 | |
| QFSDEVEPATPEEGE | 31 | P0CL81 | |
| QFSDEVEPATPEEGE | 31 | A6NDE8 | |
| QFSDEVEPATPEEGE | 31 | P0CL82 | |
| QFSDEVEPATPEEGE | 31 | A6NER3 | |
| PGTIVANITAEDPDD | 251 | Q6ZTQ4 | |
| QFSDEVEPATPEEGE | 31 | Q13070 | |
| SATEGEEPPRVAEEG | 46 | Q8WW18 | |
| DNVDPPEELGASISV | 1126 | Q9NSI6 | |
| VAGEAAETDSEPEPE | 56 | Q6QNY0 | |
| DLSSDAPGVPRIEEE | 126 | P16220 | |
| EAAPEEGSLEEAATP | 46 | Q99750 | |
| LPEVSVEAAPEGSLE | 401 | Q8IWC1 | |
| GTELAETELPDDIPS | 116 | P10911 | |
| EVSFDEPQEEATGLP | 1271 | O60307 | |
| GEDLSPEVFDESLPA | 396 | Q69YH5 | |
| QFSDEVEPATPEEGE | 31 | Q4V321 | |
| QFSDEVEPATPEEGE | 31 | Q13069 | |
| IAAQISEPEGEPETD | 4246 | P21817 | |
| PDLDVVADTGGEEDT | 146 | O75923 | |
| PGASSEEETLAEPEI | 441 | Q9C0B2 | |
| ISATEDTPEAEGEVP | 286 | Q96EK5 | |
| VPEITDAATDQGPAE | 181 | Q8IWE2 | |
| DPGEEAADGSDTVVL | 26 | O14593 | |
| DQVPALEAPEDIGST | 176 | Q96PC5 | |
| PPAGADSDSEESEAI | 246 | Q6ZVC0 | |
| TPDALAAEDVESDPG | 326 | P0C091 | |
| PGATAFLEEATAEEP | 51 | Q96C34 | |
| AEEEDGVPPTSESEL | 321 | Q9H987 | |
| GVPPTSESELDEEAF | 326 | Q9H987 | |
| ASEALTDEDIPEGVP | 2231 | O75445 | |
| SAEPIVVSSDEEGPV | 436 | Q9BQF6 | |
| AGPVSDEVLPETEGE | 641 | Q9C093 | |
| PVEADTDLLGDASPA | 121 | Q9Y6A5 | |
| GPEASDPSEELEALA | 146 | O15240 | |
| DIEEPPGAASSLEAD | 641 | Q8IWB6 | |
| GDSPVQDIDTPEVDL | 136 | O75446 | |
| ATEPGPETDADAEHI | 401 | Q86VH5 | |
| PDEAESAEAGAVPSE | 6 | O60331 | |
| QFSDEVEPATPEEGE | 31 | P0DSO3 | |
| EDPAGDPAVDALTSI | 46 | Q6ZRT6 | |
| SGAEKDVDVSEDSPP | 661 | Q05209 | |
| GAPGAEEEVEESSPL | 236 | Q9HAB3 | |
| LQEVVDDEVSGPSAP | 31 | P0DUX0 | |
| LQEVVDDEVSGPSAP | 31 | P0DTA3 | |
| LQEVVDDEVSGPSAP | 31 | P0DUD1 | |
| LDSDEGEEPSPEALV | 446 | Q9Y2K2 | |
| VPAVTPVDEESSDGE | 581 | Q9Y2K2 | |
| AEVGAPLSPDHSEEE | 556 | P23327 | |
| TSVVAPGEAPSEDAD | 4931 | Q8IVF2 | |
| DLVPEPTTGDDSDAA | 621 | P35611 | |
| GTADLEATPEARPEE | 516 | Q0VD83 | |
| EATPEARPEEELTGE | 521 | Q0VD83 | |
| TAEEKEAPSQAPEGD | 296 | Q6UXG3 | |
| GAQSPAIIDSDPVDE | 141 | Q99966 | |
| SESGAPEAAEEDPAA | 11 | P09497 | |
| EPEAEAEAASSGVPA | 446 | Q14028 | |
| DEDDLPVTGASGVPE | 666 | Q9NRJ4 | |
| SAESEVEEPARGPGE | 96 | Q8N8E2 | |
| DDPVVNPVATEDTAG | 661 | Q9BZQ8 | |
| PAEEGNDSEEVPEAS | 116 | Q16385 | |
| PETEPVGEESISDAE | 266 | Q5EBL4 | |
| GEAQPESEDVETPEA | 1881 | Q8IWN7 | |
| IEAPETEGEAQPESE | 2116 | Q8IWN7 | |
| EDEPEPELETGTQAA | 1241 | Q96PX9 | |
| LQEVVDDEVSGPSAP | 31 | P0DUX1 | |
| LQEVVDDEVSGPSAP | 31 | P0DUD2 | |
| GGDSPEHDTDIPEVD | 96 | Q9HAJ7 | |
| SAVGVTAPEEESPDA | 2176 | P22105 | |
| DLSEVELSPVGSEEP | 6 | P56693 | |
| PEVDNLLVSDATPDG | 1621 | P24821 | |
| TAEDVTAPLVDEGAP | 71 | P10636 | |
| EPDEESLVPSGENLA | 2156 | O95359 | |
| TGSSEEEEEFLEIPP | 1756 | Q12888 | |
| VDVEETLPSEPENGA | 286 | A8K0R7 | |
| DEAEASSGSEEEPAP | 111 | F5GYI3 | |
| EVAEAATGEDASSPP | 6 | Q99536 | |
| PTEDLTPGSVEEAEE | 266 | Q5T4F4 | |
| PGLPVTFIDEVDSEE | 451 | Q4KMQ1 | |
| LQEVVDDEVSGPSAP | 31 | A0A494C191 | |
| TDPVPEEGEDVAATI | 51 | P55327 | |
| LVPEDDGTASAEGPD | 166 | Q9NX00 | |
| SVPHVIEEDEEGSPV | 706 | Q6ZQQ6 | |
| DLAEVLGSEEPTEGD | 76 | Q702N8 | |
| HDGTDSPPDADEVVI | 1181 | Q9NYU2 | |
| GEEEAASLSEAAPEP | 276 | O95365 | |
| EETEAAIGAPPTATE | 556 | Q13263 | |
| STDPEEAIEDVEGPS | 1146 | Q15911 | |
| VEGPSETAADPEELA | 1156 | Q15911 | |
| TDEEEDEVGPVLPGS | 636 | Q9ULJ8 | |
| EPESGCVEIPGLSEE | 426 | Q96SB3 |